Sexually Transmitted Diseases

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, has been fighting HIV/AIDS since the 1980s when the virus was first discovered. Now, thanks to a joint effort by multiple arms of the US Department of Health and Human Services, he’s making headway.

Investigators from England report the longest adult HIV remission observed since the Berlin patient.

Over a 12-month study, there was a 13.9% increase of retention with viral load suppression among participants who received rapid viral load results following point-of-care testing.

Recognizing that many college students are in the riskiest category, agewise, for HIV, new guidelines aim to help providers be more proactive about PrEP.

Paul Sax, MD, explains how he would demystify PrEP to clinicians who are not comfortable using HIV medications.

W. David Hardy, MD, adjunct professor of medicine in the Division of Infectious Disease at Johns Hopkins University, talks about the challenges of treating patients with HIV and comorbidities.

Paul Sax, MD, explains the lack of concrete progress in the curing of HIV.

W. David Hardy, MD, discusses long-acting injectable agents in the pipeline.

Using genome sequencing, investigators have been able to identify clusters of individuals with HIV—with a particular focus on transgender women.

Women in the South look to family planning providers for more information about HIV PrEP, according a recent study in the journal Contraception.

Paul Edward Sax, MD, explains how one obstacle of HIV treatment and care is maintaining adherence.

W. David Hardy, MD, discusses the Undetectable Equals Untransmittable (U=U) movement.

A new assay distinguishes between intact and defective HIV proviruses in infected cells, a study reports.

W. David Hardy, MD, discusses how important access to PrEP is for people at high risk of contracting HIV.

A new study finds that regular use of tenofovir gel helped reduce the risk of genital herpes acquisition in women in sub-Saharan Africa.

W. David Hardy, MD, discusses the challenges health care providers encounter when it comes to patients taking PrEP.

A shocking find on a CT scan leads to an unexpected diagnosis.

ART is associated with increased waist size in some people with HIV, and a new study aims to shed light on the factors involved.

New findings show when A3A is overexpressed, latent HIV is less likely to reactivate; the opposite is also true.

South Korean investigators have identified a correlation between infection with high-risk strains of HPV and increased risk of CVD, especially among women with obesity or other cardiovascular risk factors.

In an ongoing study spanning more than 15 years, investigators have made key discoveries about how HIV and TB drugs affect pregnant and postpartum women, leading to new safety and dosing recommendations for several medications.

In 2016, 60% of adolescents had initiated the HPV vaccine series but only 16% completed the vaccination series by age 13 and 35% by age 15.

The US Preventive Services Task Force evaluated existing recommendations and reaffirmed that newborns should receive ocular antibiotic ointment at birth to prevent gonococcal ophthalmia neonatorum.

Patients who believe themselves to be at a high risk of contracting HIV are more likely to accept pre-exposure prophylaxis (PrEP) than their peers. That’s one key finding from a new study that looked at how individual factors affect PrEP uptake.

A new guideline on the management of gonorrhea has been issued by the British Association for Sexual Health and HIV.

In theory, investigators now have the tools to edit a patient’s genes to fight HIV. However, there’s a big difference between potential and reality.

A study of the approach worked wonders in China, but it may not effectively shift the burden of costs associated with testing in the US.

A new review shows transgender women face higher HIV rates than transgender men, but also finds a relative lack of data about transmen.

Mutual of Omaha will no longer deny coverage to individuals using PrEP for HIV prevention following allegations of discrimination in 2 separate legal settlements.

Investigators in Canada link larger HIV reservoir sizes to a virus gene that is more functional in one subtype of the virus, with findings which may one day contribute to the development of an HIV cure.